menu
    • menu

    Company profile for Vandria

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vandria SA, established as a biopharmaceutical spin-off from Amazentis SA, was officially incorporated in Switzerland in 2021. The company specializes in the discovery and development of innovative small molecules designed to effectively induce mitophagy for the treatment of age-related and chronic diseases. Vandria is currently in the IND-enabling stage, boasting two lead candidates who have demonstrated highly promising resu...
    Vandria SA, established as a biopharmaceutical spin-off from Amazentis SA, was officially incorporated in Switzerland in 2021. The company specializes in the discovery and development of innovative small molecules designed to effectively induce mitophagy for the treatment of age-related and chronic diseases. Vandria is currently in the IND-enabling stage, boasting two lead candidates who have demonstrated highly promising results in both in vitro and in vivo studies. Anticipated to commence in the second quarter of 2024, the first clinical trials mark a significant milestone.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VandriaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Route de la Corniche 8, 1066 Epalinges , Switzerland
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vandria.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vandria-sa/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vandria Doses First Subjects in VNA-318 Phase 1 Trial
    Vandria Doses First Subjects in VNA-318 Phase 1 Trial

    18 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/18/2998783/0/en/Vandria-announces-first-subjects-dosed-in-its-first-in-human-Phase-1-clinical-trial-of-VNA-318-brain-penetrant-mitophagy-inducer.html

    GLOBENEWSWIRE
    18 Dec 2024
    Share Share
    Vandria Raises $30.7M For CNS Clinical Development Of VNA-318
    Vandria Raises $30.7M For CNS Clinical Development Of VNA-318

    21 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/21/2933277/0/en/Hevolution-Foundation-and-Dolby-Family-Ventures-join-Vandria-s-2nd-Series-A-closing-bringing-the-total-round-to-30-7M-CHF-28-3M-to-Progress-the-Mitophagy-Inducer-VNA-318-into-CNS-C.html

    GLOBENEWSWIRE
    21 Aug 2024
    Share Share
    Vandria Awarded ‚¬3.8M in Prestigious Innosuisse and Eurostars Grants
    Vandria Awarded ‚¬3.8M in Prestigious Innosuisse and Eurostars Grants

    08 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/08/2825744/0/en/Vandria-Awarded-3-8M-in-Prestigious-Innosuisse-and-Eurostars-Grants-to-Advance-Innovative-Drug-Programs-for-Age-Related-Diseases-of-the-CNS-and-Muscle.html

    GLOBENEWSWIRE
    08 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search